by Aaron E. | Jul 19, 2024 | Market News
Introduction Cassava Sciences Inc. (NASDAQ: SAVA) is a biotechnology company at the forefront of developing innovative treatments for neurodegenerative diseases, most notably Alzheimer’s disease. With its lead therapeutic product candidate, Simufilam, Cassava...
